
Clinical Trials
Bavarian Nordic and its partners conduct clinical studies of its vaccine candidates to evaluate their safety and efficacy.
Clinical studies that are actively enrolling patients or are planned are detailed below.
Clinical trials with BN-BrachyuryClinical trials with BN-Brachyury
Ongoing or planned trials
Phase 1/2 Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, ALT-803 and Epacadostat (QuEST1) Location: USA Read more: NCT03493945 |